Sarepta Therapeutics (SRPT) Sees Increased Cash Burn
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 5/3/2024
- Wall St ends sharply higher, jobs data strengthens case for rate cuts
- U.S. adds fewer jobs than anticipated in April
- Apple shares rise more than 5% premarket after Q2 results top downbeat estimates
- Amgen (AMGN) stock soars on positive obesity drug update, analyst raises PT
- Oil settles down on US jobs data, steepest weekly loss in 3 months
- Midday movers: Apple, Amgen and Block rise; Cloudflare and Expedia fall
- After-hours movers: Apple, Block, Coinbase, Booking and more
- Midday movers: Carvana and Qualcomm rise; DoorDash, Fastly, Zillow fall
- After-hours movers: Qualcomm, Carvana rise; DoorDash, Etsy, Fastly fall
- Midday movers: Amazon, Pfizer, Pinterest rise; AMD, Starbucks, CVS Health fall
Sarepta Therapeutics (SRPT) Announces $100M Common Stock Offering
April 22, 2014 5:07 PM EDTSarepta Therapeutics (NASDAQ: SRPT) announced that it is offering to sell, subject to market and other conditions, up to $100 million of its common stock in an underwritten public offering. Sarepta also intends to grant the underwriters a... More
